Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Trivascular Technologies Inc (TRIV)

Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Trivascular Technologies Inc 3910 Brickway Boulevard Santa Rosa CA 95403

www.trivascular.com P: 707-543-8800

Description:

Trivascular Technologies, Inc. is a medical device company. It is developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company offers ovation system, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. It is also developing a short-cure fill polymer; next generation iliac limbs; ovation alto system, a next generation aortic body; and other platform applications. TriVascular Technologies, Inc. is headquartered in Santa Rosa, California.

Key Statistics

Overview:

Market Capitalization, $K 112,160
Shares Outstanding, K 20,520
Annual Sales, $ 31,800 K
Annual Net Income, $ -57,370 K
Last Quarter Sales, $ 9,460 K
Last Quarter Net Income, $ -13,580 K
60-Month Beta 2.67
% of Insider Shareholders 52.70%
% of Institutional Shareholders 62.29%

Growth:

1-Year Return -41.88%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.66 on 11/09/15
Latest Earnings Date 03/01/16
Earnings Per Share ttm -2.88
EPS Growth vs. Prev Qtr 9.59%
EPS Growth vs. Prev Year 4.35%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

TRIV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -296.18%
Return-on-Assets % -63.98%
Profit Margin % -180.41%
Debt/Equity 42.70
Price/Sales 4.69
Price/Cash Flow N/A
Price/Book 79.25
Book Value/Share 0.07
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar